Lv12
98 积分 2024-05-27 加入
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
2小时前
已关闭
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
1天前
已完结
From Chiral Separation to Asymmetric Synthesis: Route Scouting and Early Process Development of a Chiral Tetrahydrofuran–Pyrazolamine Intermediate of CDK2 Inhibitor RLY-2139
3个月前
已完结
皖公网安备34019202002308
